XOLAIR Detail

Drug Name(s):
XOLAIR

FDA Application No.:
BLA 103976

Active Ingredient(s):
OMALIZUMAB

Company:
GENENTECH

Original Approval or Tentative Approval Date:
June 19, 2003

Products on Application BLA 103976:

Active Ingredients	Strenght	Dosage Form	Marketing Status	TE Code
OMALIZUMAB	150MG/VIAL	VIAL	Prescription	none

Welcome

Did you know it can take decades for medical innovations to be widely adopted by the healthcare community? To make the best decisions for your health, you need more information than your physician alone can provide. Medicine.org is here to help you become an advocate for your own health by allowing you to share and discover the current healthcare information you need. Learn more.

Navigation

Resources

Medical Dictionary

Drug Information

Events

«	January 2009
S	M	T	W	T	F	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

Job search

Find jobs in healthcare or try morejob search engines.

About | Privacy Statement | Terms & Conditions | Contact Us | Link Resources

Medicine.org is an online community where consumers can share health resources and information. It is intended to supplement, not replace, professional medical care. Always consult your doctor for medical advice related to your specific health condition.

We comply with the HONcode standard for health trust worthy information:
verify here.

Links to Site

last updated on 01-08-2009

XOLAIR Detail

Sponsored Links

Recall Notices

Action Alerts

Active forum topics

Poll

Subscribe to our feed